RAFAEL HOLDINGS, INC. Increase (Decrease) in Accounts and Other Receivables
RAFAEL HOLDINGS, INC. (RFL) reported Increase (Decrease) in Accounts and Other Receivables of -$226.00 thousand for the 6-month period ending 2025-01-31, per its 10-Q filed 2025-03-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables · last filed 2025-03-14
- RAFAEL HOLDINGS, INC. increase (decrease) in accounts and other receivables for the quarter ending 2025-01-31 was -$1.00K, a 101.18% decline year-over-year.
- RAFAEL HOLDINGS, INC. increase (decrease) in accounts and other receivables for the quarter ending 2024-10-31 was -$225.00K, a 1350.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. increase (decrease) in accounts and other receivables for the quarter ending 2024-07-31 was -$17.00K, a 158.62% decline year-over-year.
- RAFAEL HOLDINGS, INC. increase (decrease) in accounts and other receivables for the quarter ending 2024-04-30 was $64.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in accounts and other receivables for fiscal 2024 was $150.00K, a 28.21% increase from fiscal 2023.
- RAFAEL HOLDINGS, INC. increase (decrease) in accounts and other receivables for fiscal 2023 was $117.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in accounts and other receivables for fiscal 2022 was -$74.00K, a 145.96% decline from fiscal 2021.
- RAFAEL HOLDINGS, INC. increase (decrease) in accounts and other receivables for fiscal 2021 was $161.00K.
| Period end | Increase (Decrease) in Accounts and Other Receivables 3 month | Increase (Decrease) in Accounts and Other Receivables 6 month | Increase (Decrease) in Accounts and Other Receivables 9 month | Increase (Decrease) in Accounts and Other Receivables 12 month |
|---|---|---|---|---|
| 2025-01-31 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-14 | -$226.00K 10-Q · filed 2025-03-14 | -$243.00K derived: sum of 3 quarters · filed 2025-03-14 | -$179.00K derived: sum of 4 quarters · filed 2025-03-14 |
| 2024-10-31 | -$225.00K 10-Q · filed 2024-12-11 | -$242.00K derived: sum of 2 quarters · filed 2024-12-20 | -$178.00K derived: sum of 3 quarters · filed 2024-12-20 | -$93.00K derived: sum of 4 quarters · filed 2025-03-14 |
| 2024-07-31 | -$17.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | $47.00K derived: sum of 2 quarters · filed 2024-12-20 | $132.00K derived: sum of 3 quarters · filed 2025-03-14 | $150.00K 10-K/A · filed 2024-12-20 |
| 2024-04-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-06-14 | $149.00K derived: sum of 2 quarters · filed 2025-03-14 | $167.00K 10-Q · filed 2024-06-14 | $196.00K derived: sum of 4 quarters · filed 2025-03-14 |
| 2024-01-31 | $85.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-14 | $103.00K 10-Q · filed 2025-03-14 | $132.00K derived: sum of 3 quarters · filed 2025-03-14 | $109.00K derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-10-31 | $18.00K 10-Q · filed 2024-12-11 | $47.00K derived: sum of 2 quarters · filed 2024-12-20 | $24.00K derived: sum of 3 quarters · filed 2024-12-20 | $107.00K derived: sum of 4 quarters · filed 2024-12-20 |
| 2023-07-31 | $29.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | $6.00K derived: sum of 2 quarters · filed 2024-12-20 | $89.00K derived: sum of 3 quarters · filed 2024-12-20 | $117.00K 10-K/A · filed 2024-12-20 |
| 2023-04-30 | -$23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-06-14 | $60.00K derived: sum of 2 quarters · filed 2024-06-14 | $88.00K 10-Q · filed 2024-06-14 | -$376.00K derived: sum of 4 quarters · filed 2024-06-14 |
| 2023-01-31 | $83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-03-14 | $111.00K 10-Q · filed 2024-03-14 | -$353.00K derived: sum of 3 quarters · filed 2024-03-14 | -$381.00K derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-10-31 | $28.00K 10-Q · filed 2023-12-14 | -$436.00K derived: sum of 2 quarters · filed 2023-12-14 | -$464.00K derived: sum of 3 quarters · filed 2023-12-14 | -$542.00K derived: sum of 4 quarters · filed 2023-12-14 |
| 2022-07-31 | -$464.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-30 | -$492.00K derived: sum of 2 quarters · filed 2023-10-30 | -$570.00K derived: sum of 3 quarters · filed 2023-10-30 | -$74.00K 10-K · filed 2023-10-30 |
| 2022-04-30 | -$28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | -$106.00K derived: sum of 2 quarters · filed 2023-06-13 | $390.00K 10-Q · filed 2023-06-13 | $753.00K derived: sum of 4 quarters · filed 2023-06-13 |
| 2022-01-31 | -$78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | $418.00K 10-Q · filed 2023-03-14 | $781.00K derived: sum of 3 quarters · filed 2023-03-14 | |
| 2021-10-31 | $496.00K 10-Q · filed 2022-12-13 | $859.00K derived: sum of 2 quarters · filed 2022-12-13 | ||
| 2021-07-31 | $363.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $161.00K 10-K · filed 2022-10-31 | ||
| 2021-04-30 | -$202.00K 10-Q · filed 2022-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |